RxSight (RXST) Assets Average (2021 - 2026)

RxSight's Assets Average history runs 6 years deep, the most recent figure standing at $307.9 million for Q1 2026.

• Quarterly Assets Average fell 2.5% year-over-year to $307.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $307.9 million (down 2.5% YoY) and the FY2025 annual result came in at $315.2 million, up 25.8% from the prior year.
• Assets Average was $307.9 million for Q1 2026 at RxSight, down from $310.2 million in the prior quarter.
• Across five years, Assets Average topped out at $315.8 million in Q1 2025 and bottomed at $152.9 million in Q4 2022.
• A 5-year average of $236.5 million and a median of $198.9 million in 2023 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average retreated 22.85% — and 2025, when it surged 72.7%.
• RxSight's Assets Average stood at $152.9 million in 2022, then grew by 19.14% to $182.2 million in 2023, then soared by 72.62% to $314.5 million in 2024, then retreated by 1.38% to $310.2 million in 2025, then slipped by 0.73% to $307.9 million in 2026.
• Business Quant data shows RXST's Assets Average at $307.9 million in Q1 2026, $310.2 million in Q4 2025, and $308.8 million in Q3 2025.